Dear Dr Dara

I hope this e-mail find you doing well. First of all I would like to express our sincere gratitude for all support provided to Georgia for joining the Solidarity trial. Selected clinical sites look forward to getting access to drugs and starting patients enrollment. With this e-mail I am sending the letter from Professor Tengiz Tsertsvadze for your kind review and consideration.

Please find the attached.

Thanks for your attention to my e-mail in advance.

პატივისცემით,

თამარ გაბუნია

მინისტრის პირველი მოადგილე

Sincerely,

Tamar Gabunia, MD, MPH

First Deputy Minister

Dear Solidarity Trial P.Is and esteemed colleagues,

We are pleased to be sharing with you the new WHO ‘interim’ guidance on COVID-19 clinical management (attached). This is a key documents in our collective objective to: (1) Slow and stop transmission of the virus; (2) Provide optimized care for all patients; and (3) Minimize the impact of the epidemic on health systems, social services and economic activity.

This guidance is intended for clinicians involved in the care of patients with suspected or confirmed COVID-19. As all of you copied are involved in the Solidarity Trial, we wanted to make sure you get this document and we encourage you to share this broadly within your networks. Please note that it is not meant to replace clinical judgment or specialist consultation, but rather to strengthen frontline clinical management based on the latest WHO guidance.

Furthermore, we wanted to thank you for all your hard work, dedication and time with enrolling patients in Solidarity Trial. To date, 17 countries have started Solidarity Trial in 320 hospitals around the world and where 885 clinicians including yourselves are involved. Patient enrollment has surpassed 3,000 on May 18^th – 8 weeks since the launch of the initiative on March 18 by the Director General of the WHO (Dr. Tedros). By the end of May, we expect another 10-12 countries to start enrolling patients with at least one country representing each WHO region. This is tremendous progress and we owe it to you. You should all be proud to be part of this global mega-trial to help research into an effective COVID-19 treatment and your efforts are not going unnoticed.

Of course, the battle against this pandemic is far from over and time is not on our side. The faster we can go, the quicker we can identify solutions. The international community is counting on your help to implement and accelerate all possible efforts for Solidarity Trial and to enroll as many patients as possible.

All the very best and keep safe.

Patrick

(on behalf of Dr Soumya (WHO Chief Scientist); the co-leads of Solidarity Trial (Dr Ana Maria, Dr Marie-Pierre and Dr Vasee); and our Regional and Country Office Focal points that have done an incredible job helping)

___________________________________________________________________________
Patrick Lydon

Research & Development Blueprint Unit  – WHO Health Emergencies Preparedness & Response

World Health Organization | 20 Avenue Appia | CH-1211 Geneva 27 Switzerland | Office: M1156
*: lydonp@who.int |(:office +41.22.791.4238 |(:mobile +41.79.475.5550 |(:skype: patricklydon

Promote health, keep the world safe, and serve the vulnerable